Dietary patterns and the risk of tuberculosis-drug-induced liver injury: a cohort study

Background and purposeNutrition is associated with tuberculosis drug-induced liver injury (TBLI). How dietary patterns relate to tuberculosis drug-induced liver injury is still unknown. The objective of this study is to explore the relation between dietary patterns and the risk of tuberculosis drug-induced liver injury.MethodsThis cohort study was conducted at two hospitals in Shandong Province, China, between 2011 and 2013. A total of 605 tuberculosis patients were included in the final analysis. The blood aspartate aminotransferase or alanine aminotransferase level was monitored through the 6-month tuberculosis treatment. The semi-quantitative food frequency questionnaires were used to survey dietary intake in the second month of the tuberculosis treatment. The China Healthy Diet Index (CHDI), which was previously validated in the Chinese population, was used as an a priori dietary pattern. A posteriori dietary patterns were extracted by principal component analysis (PCA).ResultsThe CHDI was negatively associated with the risk of liver injury [adjusted odds ratio (aOR) per standard deviation (SD) (95% CI): 0.61 (0.40–0.94)] and liver dysfunction [aOR per SD (95% CI): 0.47 (0.35–0.64)] in the multivariate logistic model. A positive association between “Organ meat, poultry, and vegetable oil” dietary pattern scores (extracted by PCA) and the risk of liver injury [aOR (95% CI): 3.02 (1.42–6.41)] and liver dysfunction [aOR (95% CI): 1.83 (1.09–3.05)] was observed.ConclusionIn conclusion, a high CHDI score was a protective factor for tuberculosis drug-induced liver injury, while the “Organ meat, poultry, and vegetable oil” dietary pattern, which was rich in organ meat, poultry, and vegetable oil and low in vegetables, was an independent risk factor for tuberculosis drug-induced liver injury

Comprehensive Understanding of Aluminosilicate Phosphate Geopolymers: A Critical Review

Aluminosilicate phosphate (ASP) geopolymers are a new kind of green cementitious materials synthesized from aluminosilicate precursors and acidic activators (phosphoric acid or phosphate), which have received extensive attention from researchers because of their excellent and unique characteristics. The current investigation indicates that ASP geopolymers have the characteristics of a low-carbon synthesis process, high mechanical properties (e.g., the highest compressive strength can reach 146 MPa), a strong heat resistance (e.g., withstanding a high temperature of 1500 °C), and excellent dielectric properties. These excellent properties make them have broad application prospects in the fields of new building materials, coating materials, insulating materials, and heavy metal curing. Based on the research findings of approximately 85 relevant literatures on ASP geopolymers in past decades, this paper focuses on the latest research progress of ASP geopolymers from the perspectives of synthesis processes, performances, modifications, and application developments. In addition, this study summarizes the key problems existing in the current research of ASP geopolymers and suggests their possible applications in the future, which will help to provide directions for further research activities of relevant researchers

Hydration and Properties of Magnesium Potassium Phosphate Cement Modified by Granulated Blast-Furnace Slag: Influence of Fineness

Magnesium potassium phosphate cement (MKPC) is an excellent rapid repair material for concrete, and many mineral admixtures have been applied to promote its performance. This study focuses on the quantitative characterization of the physical and chemical contributions of granulated blast-furnace slag with various finenesses to the performance development of MKPC. It was found that the addition of slag could increase the setting time, which is mainly due to the dilution of cement. Fine slag tends to decrease the fluidity of MKPC mortar. The physical contributions of ordinary and ultrafine slag to the early performance of MKPC mortar are 23% and 30%, while the chemical contributions are only 6%~10%. At late ages, the physical contribution is less than 10% and the chemical contribution of slag is even slightly negative. The addition of slag is beneficial to the compact packing of MKPC, which is the main reason for the physical contribution. Slag could react in the MKPC system, and increasing the fineness significantly promotes the reaction kinetics

Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value

Abstract Background Ovarian cancer (OC) is a severe gynecological malignancy with significant diagnostic and therapeutic challenges. The discovery of reliable cancer biomarkers can be used to adjust diagnosis and improve patient care. However, serous OC lacks effective biomarkers. We aimed to identify novel biomarkers for OC and their pathogenic causes. Methods The present study used the differentially expressed genes (DEGs) obtained from the “Limma” package and WGCNA modules for intersection analysis to obtain DEGs in OC. Three hub genes were identified—claudin 3 (CLDN3), interferon regulatory factor 6 (IRF6), and prostasin (PRSS8)—by searching for hub genes through the PPI network and verifying them in GSE14407, GSE18520, GSE66957, and TCGA + GTEx databases. The correlation between IRF6 and the prognosis of OC patients was further confirmed in Kaplan-Miller Plotter. RT-qPCR and IHC confirmed the RNA and protein levels of IRF6 in the OC samples. The effect of IRF6 on OC was explored using transwell invasion and scratch wound assays. Finally, we constructed a ceRNA network of hub genes and used bioinformatics tools to predict drug sensitivity. Results The joint analysis results of TCGA, GTEx, and GEO databases indicated that IRF6 RNA and protein levels were significantly upregulated in serous OC and were associated with OS and PFS. Cell function experiments revealed that IRF6 knockdown inhibited SKOV3 cell proliferation, migration and invasion. Conclusion IRF6 is closely correlated with OC development and progression and could be considered a novel biomarker and therapeutic target for OC patients

Microstructure and compressive behavior of lamellar Al2O3p/Al composite prepared by freeze-drying and mechanical-pressure infiltration method

Infiltrated molten Al matrix by mechanical-pressure infiltration method into the ceramic scaffold prepared by freeze-drying technology could prepare dense lamellar Al matrix composites without damage of the biomimetic microstructure of the scaffold. However, the investigation of lamellar Al matrix composites prepared by freeze-drying and mechanical-pressure infiltration method has not been fully understood yet. In the present work, the Al2O3 scaffold with pearl layer structure was prepared by freezing-dry method, and eventually the lamellar Al2O3p/Al composite was fabricated by mechanical-pressure infiltration method. The Al matrix was infiltrated well into the large pores of the Al2O3 scaffold, and the lamellar structure of the Al2O3 was well preserved. The hardness of the lamellar Al2O3p/Al composite was isotropic in transvers and perpendicular directions. However, the compressive strengths of the lamellar Al2O3p/Al composite were significant anisotropic while the compressive strength in transvers direction was 127.7% higher than that in the perpendicular direction, indicating the integrality of the lamellae microstructure (especially the bridging layers). Due to the mismatched deformability, weak debonding was observed between Al and Al2O3p/Al layers in the fracture surface of the lamellar Al2O3p/Al composite. It indicates that the interfacial bonding between Al and Al2O3p/Al layers is rather strong, which is beneficial for higher strength in transvers direction but lead to lower strength in perpendicular direction

Rationale and design of a randomized controlled trial of the effect of retinol and vitamin D supplementation on treatment in active pulmonary tuberculosis patients with diabetes

BACKGROUND: The association between pulmonary tuberculosis (PTB) and diabetes mellitus (DM) has been previously attracted much attention. Diabetes alters immunity to tuberculosis, leading to more frequent treatment failure in TB patients with DM. Moreover, TB and DM often coincide with micronutrients deficiencies, such as retinol and vitamin D, which are especially important to immunity of the body and may influence pancreas β-cell function. However, the effects of retinol and vitamin D supplementation in active TB patients with diabetes on treatment outcomes, immune and nutrition state are still uncertain. We are conducting a randomized controlled trial of vitamin A and/or D in active PTB patients with DM in a network of 4 TB treatment clinics to determine whether the supplementation could improve the outcome in the patients. METHODS/DESIGN: This is a 2×2 factorial trial. We plan to enroll 400 active PTB patients with DM, and randomize them to VA (2000 IU daily retinol); VD (400 IU daily cholecalciferol); VAD (2000 IU daily retinol plus 400 IU cholecalciferol) or control (placebo) group. Our primary outcome measure is the efficacy of anti-tuberculosis treatment and ameliorating of glucose metabolism, and the secondary outcome measure being immune and nutrition status of the subjects. Of the first 37 subjects enrolled: 8 have been randomized to VA, 10 to VD, 9 to VAD and 10 to control. To date, the sample is 97.3% Han Chinese and 91.9% female. The average fasting plasma glucose level is 12.19 mmol/L. DISCUSSION: This paper describes the design and rationale of a randomized clinical trial comparing VA and/or VD supplementation to active pulmonary TB patients with DM. Our trial will allow rigorous evaluation of the efficacy of the supplementation to active TB and DM therapy for improving clinical outcomes and immunological condition. This detailed description of trial methodology can serve as a template for the development of future treatment scheme for active TB patient with DM. TRIAL REGISTRATION: ChiCTR-TRC-1200254

Hyperglycemia is associated with increased risk of patient delay in pulmonary tuberculosis in rural areas

Background: Excessive time between the first presentation of symptoms of pulmonary tuberculosis (PTB) and diagnosis contributes to ongoing transmission and increased risk of infection in the community, as well as to increased disease severity and higher mortality. People with type 2 diabetes mellitus (T2DM) have a higher risk of developing PTB. However, the effect of T2DM on delayed diagnosis of PTB is not fully understood. This study investigated the effects of hyperglycemia (diabetes and prediabetes) and other factors on PTB patient delay in a rural area of China. Methods: In the present community-based investigation, PTB patients aged ≥16years newly diagnosed at county tuberculosis dispensaries were recruited consecutively between September 2011 and December 2013. Fasting blood glucose was determined in all subjects, and a structured questionnaire was used to collect basic information. Results: Of the 2280 patients, 605 (26.5 %) had hyperglycemia. The median (interquartile range) time to seeking health care was 44 (59) days. Health care seeking was delayed in 1754 subjects, and hyperglycemia was independently associated with an increased probability (odds ratio 2.10; 95 % confidence interval 1.49-2.97) of patient delay in subjects aged ≥30years. Other factors associated with patient delay were cough, night sweats, and lack of knowledge regarding typical tuberculosis symptoms. The onset of hemoptysis was negatively correlated with patient delay. Conclusions: Patient delay appears to be a serious problem in this rural area with a high prevalence of tuberculosis. Hyperglycemia is independently associated with an increased probability of patient delay, which, in turn, may result in more serious clinical manifestations

DataSheet_1_Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.pdf

BackgroundUncommon epidermal growth factor receptor (EGFR) mutations consist of a heterogeneous population of molecular alterations, and the available clinical data on the outcomes of patients with non-small-cell lung cancer (NSCLC) harboring uncommon EGFR mutations following afatinib treatment are limited. The purpose of this pooled analysis was to investigate the clinicopathological features of patients with uncommon EGFR mutations (um-EGFRms) along with their treatment response and survival outcomes following afatinib treatment.MethodsWe performed a literature search in the NCBI PubMed database to identify relevant articles and conducted this pooled analysis based on 70 studies. The relationships between patient clinical characteristics, EGFR mutation type and the response to afatinib treatment were analyzed using univariate chi-square analysis, and survival analysis was performed using the Kaplan–Meier method.ResultsData from a total of 99 patients were included in the pooled analysis. The objective response rate (ORR) to treatment with afatinib was53.5%, with a median progression-free survival (mPFS) of 9.0 months. For patients administered first-line afatinib treatment, the ORR and median PFS were 73.5% and 15.6 months, respectively, which were both superior to those of patients treated with second- or later-line treatments (ORR:37.0%, p ConclusionsPatients with um-EGFRms exhibit favorable but inconsistent responses and survival outcomes following afatinib treatment, which closely related to the mutation pattern and cooccurring partner mutant genes. Administering afatinib for the treatment of patients with um-EGFRm might be considered an effective treatment option in some circumstances, but this recommendation requires further clinical studies for verification.</p

Association between body mass index and diabetes mellitus in tuberculosis patients in China: a community based cross-sectional study

Abstract Background We planned to determine the association of body mass index (BMI) with diabetes mellitus (DM) and impaired fasting glucose (IFG) in Chinese pulmonary tuberculosis (PTB) patients. Methods 3,505 newly-diagnosed PTB patients registered in PTB clinics in Linyi of China between September 2010 and March 2013 were enrolled. DM and IFG were identified based on fasting plasma glucose levels. ROC analysis was used to predict the ability of screening of BMI for DM and IFG in PTB patients. Results Compared with 18.5–23.9 kg/m2, patients with DM and IFG had significantly increased trends when BMI ≥ 24.0 kg/m2, and aORs were 2.28 (95%CI 1.44–3.60) and 1.30 (95%CI 1.04–1.64), respectively. After adjustment for age, gender, and educational level, there was an increased odd in BMI ≥ 23.41 kg/m2 for IFG, and a decreased odd in BMI < 19.82 kg/m2 for DM (p < 0.05). The cut-offs of BMI for screening IFG and DM in PTB patients were 22.22 kg/m2 (AUC 0.56) and 22.34 kg/m2 (AUC 0.59). Conclusions In PTB patients, BMI is significantly associated with IFG and DM. However, the predictive power of BMI was not sufficient, so it may only be a limited screening tool for DM and IFG among PTB patients in China

Additional file 1 of Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value

Supplementary Material 1